Ivabradine hydrochloride (Lancora).
The objective of this review was to perform a systematic review of the beneficial and harmful effects of ivabradine 5 mg and 7.5 mg tablets for the treatment of stable chronic heart failure (HF) with left ventricular ejection fraction (LVEF) (d 35%) in adult patients with New York Heart Association...
Saved in:
| Format: | Electronic eBook |
|---|---|
| Language: | English |
| Published: |
Ottawa (ON) :
Canadian Agency for Drugs and Technologies in Health,
June 2017.
|
| Series: | Common drug review clinical review report.
|
| Subjects: | |
| Online Access: | http://www.ncbi.nlm.nih.gov/books/NBK533838/ Full text |
http://www.ncbi.nlm.nih.gov/books/NBK533838/
Full text
Full text
MCPHS
| Call Number: |
NCBI |
|---|